|
Volumn 175, Issue 7, 2006, Pages 733-736
|
How should developing countries manage diabetes?
a b b b b c d |
Author keywords
[No Author keywords available]
|
Indexed keywords
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HYPOCHOLESTEROLEMIC AGENT;
INSULIN;
METFORMIN;
COST EFFECTIVENESS ANALYSIS;
DEVELOPING COUNTRY;
DIABETES MELLITUS;
DIABETIC RETINOPATHY;
DIAGNOSTIC TEST;
DRUG COST;
FEASIBILITY STUDY;
GLYCEMIC CONTROL;
HEALTH CARE COST;
HEALTH SERVICE;
HUMAN;
LIFESTYLE;
PATIENT EDUCATION;
PREVALENCE;
PUBLIC HEALTH;
QUALITY OF LIFE;
REVIEW;
RISK FACTOR;
SMOKING CESSATION;
ARTICLE;
COST;
COST OF ILLNESS;
DISEASE MANAGEMENT;
ECONOMICS;
INCIDENCE;
STATISTICS;
COST OF ILLNESS;
COSTS AND COST ANALYSIS;
DEVELOPING COUNTRIES;
DIABETES COMPLICATIONS;
DIABETES MELLITUS;
DISEASE MANAGEMENT;
HEALTH CARE COSTS;
HUMANS;
INCIDENCE;
|
EID: 33749346034
PISSN: 08203946
EISSN: 14882329
Source Type: Journal
DOI: 10.1503/cmaj.060367 Document Type: Review |
Times cited : (35)
|
References (8)
|